healthy individuals
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Subjects of men and women aged 20 to 64 (2) Subjects suffering from dry or rough skin (3) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
Exclusion criteria
Exclusion criteria: (1) Subjects with heart, liver, and kidney diseases (including complications of other diseases) (2) Subjects with a history of cardiovascular disease (3) Subjects with diabetes (4) Subjects with diseases currently being treated (5) Subjects who are allergic to food and drugs (6) Female subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects (7) Subjects who play intense sports and subjects who are on a diet (8) Subjects with extremely irregular eating habits (9)Subjects who may be exposed to excessive ultraviolet rays during the test period (10)Subjects with skin abnormalities such as inflammation and eczema at the measurement site (face, arm) (11) Those who go to a beauty salon for skin care (12) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (13) Subjects who drink more than 60 g of average daily pure alcohol (14) Subjects who smoke an average of 21 or more cigarettes a day (15) Subjects who are participating in or will participate in other clinical trials at the start of this study. (16) Other subjects judged by the investigator or the investigator to be inappropriate for the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of skin condition | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of other skin condition indicators Subjective index survey | — |
Countries
Japan
Contacts
Oneness Support Co., Ltd. Clinical Trial Division